Global health perspective in sarcomas and other rare cancers
V Florou, AG Nascimento, A Gulia… - American Society of …, 2018 - ascopubs.org
… , biosimilars are an alternative to biologic agents at a lower cost. A number of biosimilars …
of and applications for biosimilars remain challenging, because biosimilars are not generics …
of and applications for biosimilars remain challenging, because biosimilars are not generics …
A phase II, multicenter, open-label trial to evaluate the safety and efficacy of ISU303 (Agalsidase beta) in patients with Fabry disease
S Hwang, BH Lee, WS Kim, DS Kim, CK Cheon… - Medicine, 2022 - journals.lww.com
… analysis was performed by linear and log-linear models. The PK of ISU303 were determined
by noncompartmental analysis … Once biosimilars are introduced, they must require close …
by noncompartmental analysis … Once biosimilars are introduced, they must require close …
State, institutional entrepreneurship and the creation of the biopharmaceutical industry in a developing country
A Babaee, AN Mashayekhi… - Journal of Science and …, 2022 - emerald.com
… Some of the biosimilars produced in Iran are the first in the … analysis to ensure that the best
understanding was developed. The researchers stopped the iteration process between theory …
understanding was developed. The researchers stopped the iteration process between theory …
Limitations of Protein Structure Prediction Algorithms in Therapeutic Protein Development
… testing when these molecules are developed as biosimilars. We also studied modified structures
… Since it was demonstrated through previous studies and a comparative analysis in this …
… Since it was demonstrated through previous studies and a comparative analysis in this …
Immunobiology of Cancer
… notion. While a series of oncogenic events characterize the progression of cancer, the
characteristics … not all malignant cells share the characteristics of the disease. Another concern is …
characteristics … not all malignant cells share the characteristics of the disease. Another concern is …
Therapeutic antibody engineering and selection strategies
J Ministro, AM Manuel, J Goncalves - Current applications of …, 2020 - Springer
… and explored to obtain chosen characteristics of selected leading candidates such as high
… The development of biosimilar antibodies, which show a similar quality, efficacy, and safety …
… The development of biosimilar antibodies, which show a similar quality, efficacy, and safety …
[图书][B] Pharmaceutical competitive intelligence for the regulatory affairs professional
RA Huml - 2012 - books.google.com
… in connection with reviews or scholarly analysis or material … in Europe or start their biosimilars
projects (for products nearing … the process of natural evolution A field of computer science …
projects (for products nearing … the process of natural evolution A field of computer science …
[图书][B] Endotoxin detection and control in pharma, limulus, and mammalian systems
KL Williams - 2019 - books.google.com
… [49] The legal basis for biosimilars in the EU is found in “Article 6 of … characterization methods,
the idea of an “identical copy” is not an acceptable one for pairing biologics and biosimilars…
the idea of an “identical copy” is not an acceptable one for pairing biologics and biosimilars…
Personalized treatment for Crohn's disease: current approaches and future directions
JW Clinton, RK Cross - Clinical and Experimental …, 2023 - Taylor & Francis
… However, one systematic review and meta-analysis suggested mild superiority of …
Additionally, with the advent of biosimilars to both IFX and ADA, these agents may be the most cost-…
Additionally, with the advent of biosimilars to both IFX and ADA, these agents may be the most cost-…
Seizing the strategic opportunities of emerging technologies by building up innovation system: monoclonal antibody development in China
… above, we conducted the data analysis in two stages. First, … in terms of the seven dimensions
as defined above. Such an … are diversified and developed as biosimilar to the foreign …
as defined above. Such an … are diversified and developed as biosimilar to the foreign …